Stocktoria

Baird Medical Investment Holdings Ltd BDMD

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-12-13

Baird Medical Investment Holdings Ltd statistics & valuation

Market cap$43.4M
P / S1.9×
P / B1.4×
Net margin-121.0%
Return on equity-87.0%
FCF margin-6.2%
Net debt$8.5M
Enterprise value USD$52.0M
Earnings yield EBIT/EV-49.3%
Return on capital-68.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
33.50% 33.60% -121.00% 202320242025
Gross margin (%)
86.60% 88.20% 83.80% 202320242025
Operating margin (%)
37.70% 41.40% -113.70% 202320242025
Return on equity (%)
29.50% 31.30% -87.00% 202320242025
Shares outstanding
29.4M 35.7M 41.0M 202320242025
Net debt ($)
$1.6M $1.5M $8.5M 202320242025
Share buybacks ($)
202320242025
Return on assets (%)
18.60% 16.00% -39.10% 202320242025
Free cash flow margin (%)
-11.60% -24.80% -6.20% 202320242025
Debt / equity (×)
0.05× 0.11× 0.28× 202320242025
EPS ($)
$0.51 $0.57 -$0.98 202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Gross margin83.8%88.2%86.6%
Operating margin-113.7%41.4%37.7%
Net margin-121.0%33.6%33.5%
FCF margin-6.2%-24.8%-11.6%
Return on assets-39.1%16.0%18.6%
Return on equity-87.0%31.3%29.5%
Debt / equity0.28×0.11×0.05×
Current ratio1.701.772.11

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.